UnitedHealth Group Faces Medicare Probe, Expects Earnings Growth in 2026
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Fool
- Executive Transition Impact: Following the appointment of CEO Steve Hemsley in May, UnitedHealth Group initiated an independent assessment of its departmental processes, and despite facing pressure from the Medicare billing probe, Hemsley stated that the review found the company's practices to be 'robust and rigorous,' laying a foundation for future improvements.
- Revenue Growth Recovery: In the latest quarter, UnitedHealth reported a 12% revenue growth and raised its full-year earnings forecast from $14.65 to $14.90 per share, reflecting positive outcomes from adjustments to plans and the adoption of artificial intelligence to enhance operational efficiency.
- Healthcare Policy Challenges: While the company anticipates earnings growth in 2026, it continues to face ongoing challenges such as government cuts to Medicare, which may impact stock performance, necessitating cautious risk assessment by investors.
- Long-Term Growth Potential: With a strong competitive advantage in both insurance and Optum services, UnitedHealth Group is well-positioned for growth, and Hemsley's proactive leadership alongside ongoing recovery measures offers promising prospects for long-term investors.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 393.95 USD with a low forecast of 260.00 USD and a high forecast of 440.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
21 Analyst Rating
17 Buy
3 Hold
1 Sell
Strong Buy
Current: 340.510
Low
260.00
Averages
393.95
High
440.00
Current: 340.510
Low
260.00
Averages
393.95
High
440.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health offers comprehensive and patient-centered care, addressing the physical, mental, social, and financial well-being. Optum Health delivers primary, specialty and surgical care; helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
